Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBLOCADE Extension Study for OUD
NCT04060654Phase 4Completed
- Sponsor
- Indivior
- Start
- Oct 2019
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of buprenorphine extended-release injection in opioid use disorder (OUD), sponsored by Indivior. Started Oct 2019; status: completed.
02
Drugs
buprenorphine extended-release injection
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT04060654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04060654.